119 related articles for article (PubMed ID: 1966596)
21. Detection of tumour antigens in sera of patients with hepatocellular carcinoma using monoclonal antibodies.
Wong LY; Chan SH; Oon CJ
Asian Pac J Allergy Immunol; 1990 Dec; 8(2):83-6. PubMed ID: 1965408
[TBL] [Abstract][Full Text] [Related]
22. Induction of allogeneic tumour- and lymphokine-activated lymphocytes against hepatocellular carcinoma.
Yasumura S; Higuchi K; Hioki O; Okada K; Tsukishiro T; Tsuchida T; Miyagiwa M; Nambu S; Yasuyama T; Inoue K
J Gastroenterol Hepatol; 1992; 7(2):136-41. PubMed ID: 1315167
[TBL] [Abstract][Full Text] [Related]
23. Surface-epitope masking: a strategy for the development of monoclonal antibodies specific for molecules expressed on the cell surface.
Shen R; Su ZZ; Olsson CA; Goldstein NI; Fisher PB
J Natl Cancer Inst; 1994 Jan; 86(2):91-8. PubMed ID: 7505832
[TBL] [Abstract][Full Text] [Related]
24. Immunological approach to hepatocellular carcinoma.
Wands JR; Lavaissiere L; Moradpour D; de la Monte S; Mohr L; Nicolau C; Tanaka S
J Viral Hepat; 1997; 4 Suppl 2():60-74. PubMed ID: 9429211
[TBL] [Abstract][Full Text] [Related]
25. Human hepatocellular carcinoma: cross-reactive and idiotypic antigens associated with malignant transformation of epithelial cells.
Wiedmann KH; Trejdosiewicz LK; Southgate J; Thomas HC
Hepatology; 1987; 7(3):543-50. PubMed ID: 2437001
[TBL] [Abstract][Full Text] [Related]
26. Immunization with UV-induced apoptotic cells generates monoclonal antibodies against proteins differentially expressed in hepatocellular carcinoma cell lines.
Celikkaya H; Ciraci C; Oztas E; Avci ME; Ozturk M; Yagci T
Hybridoma (Larchmt); 2007 Apr; 26(2):55-61. PubMed ID: 17451351
[TBL] [Abstract][Full Text] [Related]
27. Nuclear antigens reacted with sera and ascites of hepatocellular carcinoma patients.
Chen YM; Hu CP; Chen PH; Chu MH; Tsai YT; Lee SD; Chang CM
Hepatology; 1988; 8(3):547-52. PubMed ID: 2836290
[TBL] [Abstract][Full Text] [Related]
28. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.
Hiraiwa N; Tsuyuoka K; Li YT; Tanaka M; Seno T; Okubo Y; Fukuda Y; Imura H; Kannagi R
Cancer Res; 1990 Sep; 50(17):5497-503. PubMed ID: 2167157
[TBL] [Abstract][Full Text] [Related]
29. [Localization of hepatocellular carcinoma with monoclonal antibodies].
Liu Y
Zhonghua Yi Xue Za Zhi; 1991 Jul; 71(7):362-5, 26. PubMed ID: 1659475
[TBL] [Abstract][Full Text] [Related]
30. A new tumor-associated antigen useful for serodiagnosis of hepatocellular carcinoma, defined by monoclonal antibody KM-2.
Kumagai Y; Chiba J; Sata T; Ohtaki S; Mitamura K
Cancer Res; 1992 Sep; 52(18):4987-94. PubMed ID: 1381274
[TBL] [Abstract][Full Text] [Related]
31. Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma.
Uemura M; Nouso K; Kobayashi Y; Tanaka H; Nakamura S; Higashi T; Ono T; Nakayama E; Hanafusa T; Shiratori Y
Cancer; 2003 May; 97(10):2474-9. PubMed ID: 12733146
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
Saxton RE; Mann BD; Morton DL; Burk MW
Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
[TBL] [Abstract][Full Text] [Related]
33. Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma.
Kaji K; Mizukoshi E; Yamashita T; Arai K; Sunagozaka H; Fushimi K; Nakagawa H; Yamada K; Terashima T; Kitahara M; Kaneko S
PLoS One; 2017; 12(1):e0170291. PubMed ID: 28114424
[TBL] [Abstract][Full Text] [Related]
34. Differentiation status of rat ductal cells and ethionine-induced hepatic carcinomas defined with surface-reactive monoclonal antibodies.
Hixson DC; Brown J; McBride AC; Affigne S
Exp Mol Pathol; 2000 Jun; 68(3):152-69. PubMed ID: 10816384
[TBL] [Abstract][Full Text] [Related]
35. [Action of monoclonal antibody against a hepatocellular carcinoma cell line (PLC/PRF/5)].
Shao RP
Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):259-61. PubMed ID: 3019621
[TBL] [Abstract][Full Text] [Related]
36. Human monoclonal IgM antibodies from foetal B-cell hybridomas directed against a surface antigen on human tumour cells.
Bohn J; Josimovic-Alasevic O; Settmacher U; Kiessig ST; Lukowsky A; Volk HD; Diamantstein T; Von Baehr R; Jahn S
Res Immunol; 1992; 143(9):879-91. PubMed ID: 1289988
[TBL] [Abstract][Full Text] [Related]
37. Production of monoclonal antibodies against human hepatocellular carcinoma by immunisation with a cell membrane preparation.
Tan LS
Ann Acad Med Singap; 1990 Mar; 19(2):147-51. PubMed ID: 1693262
[TBL] [Abstract][Full Text] [Related]
38. Expression of the SART1 tumor-rejection antigen in hepatocellular carcinomas.
Yutani S; Shichijo S; Inoue Y; Kawagoe N; Okuda K; Kurohiji T; Tanaka M; Sata M; Itoh K
Oncol Rep; 2001; 8(2):369-72. PubMed ID: 11182058
[TBL] [Abstract][Full Text] [Related]
39. Murine hybridoma antibodies against human transitional carcinoma-associated antigens.
Messing EM; Bubbers JE; Whitmore KE; deKernion JB; Nestor MS; Fahey JL
J Urol; 1984 Jul; 132(1):167-72. PubMed ID: 6202893
[TBL] [Abstract][Full Text] [Related]
40. A live cell enzyme-linked immunosorbent assay for detecting human hepatoma membrane antigens.
Gaffar SA; Li Z; Epstein AL
Hybridoma; 1989 Jun; 8(3):331-6. PubMed ID: 2545598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
